Current status and prospects of primary immunodeficiency diseases in Asia

被引：20
作者：
Pilania, Rakesh Kumar [1 ]
Chaudhary, Himanshi [1 ]
Jindal, Ankur Kumar [1 ]
Rawat, Amit [1 ]
Singh, Surjit [1 ]
机构：
[1] Postgrad Inst Med Educ & Res, Dept Pediat, Allergy Immunol Unit, Adv Pediat Ctr, Sect 12, Chandigarh 160012, India
来源：
GENES & DISEASES | 2020年 / 7卷 / 01期
关键词：
Asia; Genetic diagnosis; Hematopoietic stem cell transplant; Intravenous immunoglobulin; Primary immunodeficiency diseases; STEM-CELL TRANSPLANTATION; X-LINKED AGAMMAGLOBULINEMIA; REPLACEMENT THERAPY; NATIONWIDE SURVEY; INBORN-ERRORS; EXPERIENCE; DIAGNOSIS; INFECTIONS; IMMUNOGLOBULIN; EPIDEMIOLOGY;
D O I：
10.1016/j.gendis.2019.09.004
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Primary Immunodeficiency Diseases (PIDs) are increasingly being reported across the World. Several advances have been made in the diagnostic and therapeutic research related to PIDs. With increasing awareness, the field of PIDs has rapidly evolved in Asia as well. In this review, we summarize the progress that has been made in the field of PIDs in Asian countries; major limitations and challenges faced by the clinicians working in this field in Asia; difference in spectrum of PIDs in Asia from rest of the World; current state of diagnostic and treatment facilities available in various countries in Asia and the future prospects of these diseases in the continent. Copyright (C) 2019, Chongqing Medical University. Production and hosting by Elsevier B.V.
引用
收藏
页码：3 / 11
页数：9
相关论文
共 50 条
  • [41] Primary Immunodeficiency Diseases: An Opportunity in Pediatrics for Improving Patient Outcomes
    Hernandez-Trujillo, Vivian P.
    Scalchunes, Chris
    Hernandez-Trujillo, Hillary S.
    Boyle, John
    Williams, Paul
    Boyle, Marcia
    Orange, Jordan S.
    CLINICAL PEDIATRICS, 2015, 54 (13) : 1265 - 1275
  • [42] Primary immunodeficiencies: a decade of shifting paradigms, the current status and the emergence of cutting-edge therapies and diagnostics
    Ebadi, Maryam
    Aghamohammadi, Asghar
    Rezaei, Nima
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (01) : 117 - 139
  • [43] The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment
    Rezaei, Nima
    Mohammadinejad, Payam
    Aghamohammadi, Asghar
    YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY I, 2011, 1238 : 24 - 32
  • [44] Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases
    Wasserman, Richard L.
    Gupta, Sudhir
    Stein, Mark
    Rabbat, Christopher J.
    Engl, Werner
    Leibl, Heinz
    Yel, Leman
    IMMUNOTHERAPY, 2022, 14 (04) : 215 - 224
  • [45] Asian Schistosomiasis: Current Status and Prospects for Control Leading to Elimination
    Gordon, Catherine A.
    Kurscheid, Johanna
    Williams, Gail M.
    Clements, Archie C. A.
    Li, Yuesheng
    Zhou, Xiao-Nong
    Utzinger, Jurg
    McManus, Donald P.
    Gray, Darren J.
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2019, 4 (01)
  • [46] Guardians of Immunity: Advances in Primary Immunodeficiency Disorders and Management
    Peddi, Nikhil Chowdary
    Vuppalapati, Sravya
    Sreenivasulu, Himabindu
    Muppalla, Sudheer kumar
    Pulliahgaru, Apeksha Reddy
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [47] Intercultural communication in Asia: current state and future prospects
    Kim, Min-Sun
    ASIAN JOURNAL OF COMMUNICATION, 2010, 20 (02) : 166 - 180
  • [48] Endocrine complications in primary immunodeficiency diseases in Japan
    Nozaki, Takafumi
    Takada, Hidetoshi
    Ishimura, Masataka
    Ihara, Kenji
    Imai, Kohsuke
    Morio, Tomohiro
    Kobayashi, Masao
    Nonoyama, Shigeaki
    Hara, Toshiro
    CLINICAL ENDOCRINOLOGY, 2012, 77 (04) : 628 - 634
  • [49] Primary Immunodeficiency Diseases Associated with Neurologic Manifestations
    Soodabeh Fazeli Dehkordy
    Asghar Aghamohammadi
    Hans D. Ochs
    Nima Rezaei
    Journal of Clinical Immunology, 2012, 32 : 1 - 24
  • [50] Efficacy and safety of Gammaplex® 5% in children and adolescents with primary immunodeficiency diseases
    Melamed, I. R.
    Gupta, S.
    Bobbitt, M. Stratford
    Hyland, N.
    Moy, J. N.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 184 (02) : 228 - 236
12345